南方医科大学珠江医院Zhujiang Hospital of Southern Medical University

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Guangzhou 广州市

   已发表研究

   • Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancer. Clinical and translational medicine, 2026
   • Metabolic and Inflammatory Markers of Fatty Liver As Associated Factors of Hepatic Metastatic Spread in Colorectal Cancer. Cureus, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

2. Breast cancer

   Guangzhou 广州市

   已发表研究

   • MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer. Cancer biology & therapy, 2025
   • O-GlcNAcylation of NSD2 promotes lung metastasis of triple-negative breast cancer through extracellular matrix remodeling. Biochemical and biophysical research communications, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

3. Lung cancer

   Guangzhou 广州市

   已发表研究

   • Risk stratification of PD-L1 expression in non-small cell lung cancer: a predictive model for prognosis. Journal of thoracic disease, 2026
   • Effectiveness of an Interdisciplinary Integrated Care Model on Perioperative Outcomes in Patients Undergoing Lung Cancer Surgery: A Randomized Controlled Trial. ANZ journal of surgery, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

4. Liver cancer

   Guangzhou 广州市

   已发表研究

   • Bibliometric analysis of application of radiomics and artificial intelligence integration in personalized treatment of hepatocellular carcinoma. International journal of surgery (London, England), 2025

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

5. Cervical cancer

   Guangzhou 广州市

   已发表研究

   • Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial. Nature communications, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

6. Stomach cancer

   Guangzhou 广州市

   已发表研究

   • Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial. Journal of the National Cancer Institute, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

7. Thyroid cancer

   Guangzhou 广州市

   已发表研究

   • RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer. European journal of nuclear medicine and molecular imaging, 2025
   • Predicting persistent/recurrent cervical lymph node metastasis in papillary thyroid carcinoma with PET/CT-based multimodal radiomics: an image-pathology matching study. Nuclear medicine communications, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

8. Nasopharyngeal carcinoma

   Guangzhou 广州市

   已发表研究

   • Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study. Signal transduction and targeted therapy, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 核医学 获提名。

9. Brain tumour

   Guangzhou 广州市

   国家临床重点专科

   • Neurosurgery（A 级） https://www.smu.edu.cn/info/1139/13769.htm

   同时上榜：在复旦榜中为 核医学 获提名。